Predominant functional activity of the large, neutral amino acid transporter (LAT1) isoform at the cerebrovasculature

Neuroscience Letters

Volumn 306, Issue 1-2, 2001, Pages 1-4

  Killian, Dennis M ^a   Chikhale, Prashant J ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

Amino acids; Blood brain barrier; Brain perfusion; Carrier mediated transport; Large neutral amino acid transporter

Indexed keywords

AMINO ACID TRANSPORTER; ASPARAGINE; CARBON 14; CARRIER PROTEINS AND BINDING PROTEINS; LARGE NEUTRAL AMINO ACID TRANSPORTER 2; LEUCINE; METHIONINE; TRACER; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMINO ACID TRANSPORT SYSTEMS; AMINO ACIDS; ANIMALS; BINDING, COMPETITIVE; BLOOD-BRAIN BARRIER; CARBON RADIOISOTOPES; CARRIER PROTEINS; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; ENDOTHELIUM, VASCULAR; MALE; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; TRITIUM;

EID: 0035933610     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(01)01810-9     Document Type: Article

References (15)

1. Selective expression of the large neutral amino acid transporter at the blood-brain barrier
2. Carrier-mediated transport of the anti-tumor agent acivicin across the blood-brain barrier
3. The permeability of capillaries in various organs as determined by use of the 'indicator diffusion' method
4. Capillary permeability to small solutes Section 2: Part 1
5. Glutamine uptake at the blood-brain barrier is mediated by N-system transport
6. +-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids
7. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98)
8. A bioreversible prodrug approach designed to shift mechanism of brain uptake for amino acid-containing anticancer agents
9. Modulating blood-brain barrier interactions of amino acid-based anticancer agents
10. Identification of a membrane protein, LAT-2, that co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids
11. Drug entry into and distribution within brain and cerebrospinal fluid
12. Drug entry into the brain
13. +-independent neutral amino acid transporter with broad substrate selectivity
14. Kinetics of neutral amino acid transport across the blood-brain barrier
15. An in situ brain perfusion technique to study cerebrovascular transport in the rat